Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), Anti-CD38 MAb, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3
### Instruction:
Identify the study with the following condition. 
### Input:
Daratumumab+Velcade (Bortezomib) +Melphalan+Prednisone (D-VMP), Velcade (Bortezomib) +Melphalan+Prednisone (VMP), Anti-CD38 MAb, Newly Diagnosed Multiple Myeloma (NDMM), Phase 3 
### Output:
Popular Name is ALCYONE, Study ID is NCT02195479